This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lindmark, D. G. Articles by Müller, M. Search for Related Content PubMed PubMed Citation Articles by Lindmark, D. G. Articles by Müller, M.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1976 September; 10(3): 476-482
Copyright © 1976 American Society for Microbiology. All Rights Reserved.

Antitrichomonad Action, Mutagenicity, and Reduction of Metronidazole and Other Nitroimidazoles

¹ The Rockefeller University, New York, New York 10021

ABSTRACT

Twelve 4- and 5-nitroimidazole derivatives, including metronidazole and two of its metabolites, tinidazole, dimetridazole, and nimorazole, were tested for antitrichomonad action on Tritrichomonas foetus (KV₁) and Trichomonas vaginalis (ATCC 30001) for mutagenicity on a nitroreductase-positive (TA 100) and a nitroreductase-deficient (TA 100-FR₁) strain of Salmonella typhimurium, as well as for the reducibility of the nitro group by T. foetus homogenates. Compounds with activity <1% of that of metronidazole are regarded as inactive. All antitrichomonad compounds induce mutations and can be reduced. S. typhimurium TA 100 gave mutations under both aerobiosis and anaerobiosis; TA 100-FR₁, however, gave mutations only under anaerobiosis. Certain compounds that are reducible, and the nonreducible derivatives, were inactive. Metronidazole and its inactive 4-nitro analogue were reduced in a four-electron process in ferredoxin- or methyl viologen-mediated reactions with the same velocity. The results underscore the role of the reduction of the nitro group in the antitrichomonad and in the mutagenic activity of nitroimidazoles.

This article has been cited by other articles:

• Hrdy, I., Cammack, R., Stopka, P., Kulda, J., Tachezy, J. (2005). Alternative Pathway of Metronidazole Activation in Trichomonas vaginalis Hydrogenosomes. Antimicrob. Agents Chemother. 49: 5033-5036 [Abstract] [Full Text]  
• Kikuchi, Y., Ohara, N., Sato, K., Yoshimura, M., Yukitake, H., Sakai, E., Shoji, M., Naito, M., Nakayama, K. (2005). Novel stationary-phase-upregulated protein of Porphyromonas gingivalis influences production of superoxide dismutase, thiol peroxidase and thioredoxin. Microbiology 151: 841-853 [Abstract] [Full Text]  
• Cudmore, S. L., Delgaty, K. L., Hayward-McClelland, S. F., Petrin, D. P., Garber, G. E. (2004). Treatment of Infections Caused by Metronidazole-Resistant Trichomonas vaginalis. Clin. Microbiol. Rev. 17: 783-793 [Abstract] [Full Text]  
• Gardner, T. B., Hill, D. R. (2001). Treatment of Giardiasis. Clin. Microbiol. Rev. 14: 114-128 [Abstract] [Full Text]  
• Touati, E., Hofnung, M., Thiberge, J.-M., Michel, V., Labigne, A., Jenks, P. J. (2000). Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice. J Antimicrob Chemother 46: 987-992 [Abstract] [Full Text]  
• Sisson, G., Jeong, J.-Y., Goodwin, A., Bryden, L., Rossler, N., Lim-Morrison, S., Raudonikiene, A., Berg, D. E., Hoffman, P. S. (2000). Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and in Escherichia coli Containing a Cloned H. pylori rdxA+ (Nitroreductase) Gene. J. Bacteriol. 182: 5091-5096 [Abstract] [Full Text]  
• Kwon, D.-H., El-Zaatari, F. A. K., Kato, M., Osato, M. S., Reddy, R., Yamaoka, Y., Graham, D. Y. (2000). Analysis of rdxA and Involvement of Additional Genes Encoding NAD(P)H Flavin Oxidoreductase (FrxA) and Ferredoxin-Like Protein (FdxB) in Metronidazole Resistance of Helicobacter pylori. Antimicrob. Agents Chemother. 44: 2133-2142 [Abstract] [Full Text]